Risks associated with IVF in SLE and/or APS. Values are the number of IVF procedures.
| Variables | SLE | SLE + aPL | SLE + APS | APS | Total |
|---|---|---|---|---|---|
| Patients | 15 | 8 | 4 | 10 | 37 |
| IVF procedures | 37 | 20 | 8 | 32 | 97 |
| SLE flare | 1 | 0 | 2 | 0 | 3 |
| SLE inaugural signs and first diagnosis | 1 | 0 | 0 | 0 | 1 |
| Thromboembolic events | 0 | 0 | 2 | 2 | 4 |
| OHSS | 0 | 0 | 0 | 0 | 0 |
| Uncomplicated IVF | 35 | 20 | 4 | 30 | 89 |
Significant data are in bold face. IVF: in vitro fertilization; SLE: systemic lupus erythematosus; APS: antiphospholipid syndrome; aPL: antiphospholipid antibodies; OHSS: ovarian hyperstimulation syndrome.